1 How many products is obj,s technoledgy being tried on? A: No products,our technoledgy is being tested on dozzens of applications.
2 Are any of the products being tested new products,particulary gsk? A: Particular applications are being tested.
3 Will obj be listed on any other stock exchange? A: The board has not considered this.
4 What is the stratedgy for obj,s in house pain relief patch,where and how will it be developed,what is the anticipated timeframe to get to market. A: As you would know from the agm presentation its to do with the nee guards and your answers are in the agm presentation.
5 To how many companies has obj introduced the technoledgy to? A: Dozzens,all the largest companies in the world.
6 Do you think obj should hire a marketing company or more marketing personnel? A: Dr keven hammond is handeling this and at this stage it is to early to hire more personnel.
7 What do you think the outlook is for obj over the next 12 months? A: I dont like to speculate but we hope to have at least one licencing agreement in place.
8 How many companies is obj in negotiations with? A: five
9 And of those in negotiations,how many products? A: These companies have not disclosed to us the amount of applications.
10 Why has obj filed and then let lapse or has withdrawn all but 1 of 17 patent applications,there is only 1 application currently pending in the australian patent office and none of the 16 patent applications that were withdrawn or lapsed has been granted? A: You have to apply in australia first then they go international to the pct,we may let some lapse as certain fields may not be commercially viable with our partnering companies.Jeff edwards answered this question.
11 When can we expect a consolidation of the share registry?if ever? A: Its never been discusted by the board
12 Has any company walked away from negotiations or turned down the company recently,past 12 months? A: None,cant think of any,no programs have been abondoned.
13 Is fmcg 1 still interested and progresing with obj in respect of its over the counter drug product? As was mentioned that discussions were continuing and another party was interested,when would you consider taking it to the other party? A: We are working agresivly with both companies over different catogories not products,no programs have been abandonded
14 Would a partner agreement involving the adoption of obj technoledgy on a corporate platform allow certain products to be commerciallized before being announced to the market? A: No,anything at all would need to be announced to the market.
After my conversation with glyn it is important that holders understand that it is applications that obj,s technoledgies are being tested on and that it is not about commercialzation of a product in most cases but achieving a fee agreement for the use of obj,s tech in regards to a application. Also most of these answers are a short version as he gave so much detail and I cant remember it all off hand,im a slow writer. Here is some aditional information I took notes on. Our patches are high complexted to simple applications. Obj sponsored products business case will be ready into the new year. Obj is undertaking in house tests on humane skin. Negotiations in the usa should be concluded over the next few months. Over the next year we will be progressing to more of a development stage. Obj is the only company in the world offering magnetic micro array delivery over different fields. Patches will be offered to partners with a 5 to 10 year shelf life. There was a 30 fold permitation increase for a cancer drug(ala?)that was tested with a partners product that they were having problems with permitation. Whole new commercial products are being looked at with cosmetic clients that have been having trouble with permitation(home facials?)
OBJ Price at posting:
1.9¢ Sentiment: Buy Disclosure: Held
(20min delay)